3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
7
Recurrence
2
Prostatic Neoplasms
2
Neoplasms
2
Colonic Neoplasms
2
Smoking Cessation
1
Pathologic Processes
1
Ovarian Cancer Prevention
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms by Site
1
Motor Activity
1
Lung Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Hairy Cell
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Inflammation
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Disease Attributes
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colonic Diseases
1
Breast Neoplasms
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
Surveys and Questionnaires
2
Standard of Care
2
Radiosurgery
2
Practice Guidelines as Topic
2
Oxaliplatin
2
Nivolumab
2
Leucovorin
2
Fluorouracil
2
tislelizumab
1
irinotecan sucrosofate
1
folfirinox
1
fludarabine
1
encorafenib
1
durvalumab
1
canakinumab
1
avatrombopag
1
aldesleukin
1
Transurethral Resection of Prostate
1
Sodium Chloride
1
Restraint, Physical
1
Remote Patient Monitoring
1
Radiotherapy
1
Psilocybin
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Panitumumab
1
Observation
1
Massage
1
Magnetic Resonance Spectroscopy
1
Levoleucovorin
1
Irinotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Gastrointestinal Neoplasms
×
Aspirin
×
Clear all
NCT03464305
2024-03-19
ASPIRIN
University Hospital, Antwerp
Phase 3
Active not recruiting
148 enrolled